| Patents for A61P 23 - Anaesthetics (4,141) |
|---|
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | US20020013331 For therapy of pain associated with mucosal damage, such as inflamation, abrasions, ulcerations, lesions, incisions, and trauma |
| 01/31/2002 | CA2416544A1 Mu-conopeptides |
| 01/30/2002 | CN1333677A Composition set and kit for use in intraocular surgery |
| 01/24/2002 | WO2002005786A1 Pharmaceutical composition improved in peroral absorbability |
| 01/24/2002 | US20020009478 Aqueous liquid containing colloidal particles |
| 01/23/2002 | EP1174178A1 Process and plant for dynamic gas conditioning, in particular for medical use |
| 01/23/2002 | EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 01/17/2002 | US20020006947 Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof |
| 01/17/2002 | US20020006442 Injectable aqueous dispersions of propofol |
| 01/17/2002 | US20020005028 Methods of producing a terminally sterilized topical patch preparation |
| 01/16/2002 | EP1171081A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | CN1331582A Propofol compsn. comprising gentetate |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/10/2002 | US20020004484 Topical anesthetic/opioid formulations and uses thereof |
| 01/10/2002 | US20020004063 Methods and apparatus for drug delivery involving phase changing formulations |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 01/09/2002 | EP1170020A1 Patches for external use |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/08/2002 | US6337423 Bind to voltage-gated sodium ion channels to modulate activity |
| 01/03/2002 | WO2002000715A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | WO2002000195A2 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | WO2001070744A3 Process for the preparation of midazolam |
| 01/03/2002 | WO2001064187A3 Anaesthetic formulations |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413545A1 Methods and compositions for treating pain of the mucous membrane |
| 01/02/2002 | EP1165487A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 01/02/2002 | EP1165046A1 Propofol compositions containing preservative additives |
| 01/02/2002 | EP1165045A1 Propofol formulation with enhanced microbial characteristics |
| 01/02/2002 | EP1164991A1 Gels formed by the interaction of poly(aldehyde) with various substances |
| 01/01/2002 | US6335354 Aminopyridines and methods of using thereof |
| 12/27/2001 | WO2001098265A2 Process for isolating enantiomers of racemic cetamine |
| 12/27/2001 | WO2001097796A1 Clear aqueous anaesthetic composition |
| 12/27/2001 | WO2001097782A1 Stable gabapentin having ph within a controlled range |
| 12/27/2001 | WO2001097779A2 Improved injectable dispersions of propofol |
| 12/27/2001 | US20010056125 Local anesthetic methods and kits |
| 12/27/2001 | CA2414064A1 Clear aqueous anaesthetic composition |
| 12/27/2001 | CA2412905A1 Improved injectable dispersions of propofol |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/13/2001 | WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 12/13/2001 | WO2001093856A1 Medical composition kit for treating lesioned abnormal tissue |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | WO2001047508A3 Combination of trimebutine with an opioid analgesic |
| 12/13/2001 | US20010051595 Injection into blood |
| 12/13/2001 | CA2411069A1 The human voltage gated sodium channel .beta.-1a subunit and methods of use |
| 12/12/2001 | EP1161951A1 Selenocosmia huwena toxin and analgesic uses thereof |
| 12/12/2001 | EP1161226A1 Phosphocholine linked prodrug derivatives |
| 12/11/2001 | US6329520 Used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases or in determining doses of therapeutic agents that occupy many receptors |
| 12/11/2001 | US6328708 Device for controlled anaesthesia, analgesia and /or sedation |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | CN1325291A Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 12/04/2001 | US6326406 Heating aqueous solution containing lecithin and bile acid salt |
| 12/04/2001 | US6326027 Solid, oral dosage form, comprising tramadol or its salt in matrix providing at least twelve hour effectiveness |
| 11/29/2001 | WO2001089474A2 O/w emulsion |
| 11/29/2001 | CA2407764A1 O/w emulsion |
| 11/27/2001 | US6323204 Analgesics, antiinflammatory agents and antiischemic agents |
| 11/27/2001 | US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation |
| 11/22/2001 | WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof |
| 11/22/2001 | WO2001047559A9 Patches for external use |
| 11/22/2001 | US20010044428 Aminopyridines and methods of using thereof |
| 11/21/2001 | CN1074918C Use of Ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motion blockade |
| 11/20/2001 | US6319513 Oral liquid mucoadhesive compounds |
| 11/15/2001 | WO2001085171A1 Local anesthetic methods and kits |
| 11/15/2001 | US20010041711 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (ORL1) receptor |
| 11/13/2001 | US6316021 Extensible mask including an adhesive matrix that can be stretched at least in the wet state |
| 11/08/2001 | WO2001082914A2 Topical anesthetic/opioid formulations and uses thereof |
| 11/07/2001 | EP1150658A2 Method for controlling liposome size |
| 11/06/2001 | US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants |
| 11/01/2001 | WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 11/01/2001 | US20010036477 Oral administering |
| 11/01/2001 | CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 10/31/2001 | EP1149836A1 Polynalbuphine derivatives |
| 10/31/2001 | EP1148887A2 Regulation of anaesthesia |
| 10/31/2001 | EP0877026B1 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 10/31/2001 | CN1320034A Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacturing of medicament for intraspinal, intrathecal or epidural edministration |
| 10/30/2001 | US6310252 As topical anaesthetics |
| 10/30/2001 | US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 10/24/2001 | CN1073414C Anaesthetic |
| 10/23/2001 | US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 10/23/2001 | CA2161009C Analgesic anaesthetic compositions |
| 10/18/2001 | WO2001077089A1 New neurokinin antagonists for use as medicaments |
| 10/18/2001 | WO2001076599A1 Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free base form |
| 10/18/2001 | DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system |
| 10/17/2001 | EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 10/17/2001 | EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers |
| 10/17/2001 | EP0877025B1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 10/17/2001 | EP0751766B1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 10/17/2001 | CN1317312A High-speed transcutaneous narcotic liquid |
| 10/16/2001 | US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease |
| 10/11/2001 | WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | WO2001074400A1 Transporters and drug delivery system by using the same |
| 10/11/2001 | CA2403991A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/10/2001 | EP1140095A1 (2-imidazoline-2-ylamino) quinoxaline derivatives for the treatment of pain |
| 10/10/2001 | EP1140016A1 Composition set and kit for use in intraocular surgery |
| 10/09/2001 | US6299902 Absorption |
| 10/04/2001 | WO2001072714A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 10/04/2001 | WO2001072279A2 Medical emulsion for lubrication and delivery of drugs |